Literature DB >> 10587644

CUL-2 is required for the G1-to-S-phase transition and mitotic chromosome condensation in Caenorhabditis elegans.

H Feng1, W Zhong, G Punkosdy, S Gu, L Zhou, E K Seabolt, E T Kipreos.   

Abstract

The human cullin protein CUL-2 functions in a ubiquitin-ligase complex with the von Hippel-Lindau (VHL) tumour suppressor protein. Here we show that, in Caenorhabditis elegans, cul-2 is expressed in proliferating cells and is required at two distinct points in the cell cycle, the G1-to-S-phase transition and mitosis. cul-2 mutant germ cells undergo a G1-phase arrest that correlates with accumulation of CKI-1, a member of the CIP/KIP family of cyclin-dependent-kinase inhibitors. In cul-2 mutant embryos, mitotic chromosomes are unable to condense, leading to unequal DNA segregation, chromosome bridging and the formation of multiple nuclei.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587644     DOI: 10.1038/70272

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  53 in total

1.  Targeting p21 degradation locally.

Authors:  Yue Xiong
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

2.  CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.

Authors:  Natalia G Starostina; Jennifer M Simpliciano; Michael A McGuirk; Edward T Kipreos
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

3.  VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.

Authors:  Takumi Kamura; Katsumi Maenaka; Shuhei Kotoshiba; Masaki Matsumoto; Daisuke Kohda; Ronald C Conaway; Joan Weliky Conaway; Keiichi I Nakayama
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

4.  The Caenorhabditis elegans cell-cycle regulator ZYG-11 defines a conserved family of CUL-2 complex components.

Authors:  Srividya Vasudevan; Natalia G Starostina; Edward T Kipreos
Journal:  EMBO Rep       Date:  2007-02-16       Impact factor: 8.807

5.  The CRL2LRR-1 ubiquitin ligase regulates cell cycle progression during C. elegans development.

Authors:  Jorge Merlet; Julien Burger; Nicolas Tavernier; Bénédicte Richaudeau; José-Eduardo Gomes; Lionel Pintard
Journal:  Development       Date:  2010-11       Impact factor: 6.868

6.  Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.

Authors:  Sanggyu Lee; Jianjun Chen; Guolin Zhou; Run Zhang Shi; Gerard G Bouffard; Masha Kocherginsky; Xijin Ge; Miao Sun; Nimanthi Jayathilaka; Yeong Cheol Kim; Neelmini Emmanuel; Stefan K Bohlander; Mark Minden; Justin Kline; Ozden Ozer; Richard A Larson; Michelle M LeBeau; Eric D Green; Jeffery Trent; Theodore Karrison; Piu Paul Liu; San Ming Wang; Janet D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

7.  Cyclin E and CDK-2 regulate proliferative cell fate and cell cycle progression in the C. elegans germline.

Authors:  Paul M Fox; Valarie E Vought; Momoyo Hanazawa; Min-Ho Lee; Eleanor M Maine; Tim Schedl
Journal:  Development       Date:  2011-06       Impact factor: 6.868

8.  mir-35 is involved in intestine cell G1/S transition and germ cell proliferation in C. elegans.

Authors:  Min Liu; Pengpeng Liu; Li Zhang; Qingchun Cai; Ge Gao; Wenxia Zhang; Zuoyan Zhu; Dong Liu; Qichang Fan
Journal:  Cell Res       Date:  2011-06-21       Impact factor: 25.617

9.  FBF represses the Cip/Kip cell-cycle inhibitor CKI-2 to promote self-renewal of germline stem cells in C. elegans.

Authors:  Irene Kalchhauser; Brian M Farley; Sandra Pauli; Sean P Ryder; Rafal Ciosk
Journal:  EMBO J       Date:  2011-08-05       Impact factor: 11.598

10.  Cell cycle features of C. elegans germline stem/progenitor cells vary temporally and spatially.

Authors:  Debasmita Roy; David Michaelson; Tsivia Hochman; Anthony Santella; Zhirong Bao; Judith D Goldberg; E Jane Albert Hubbard
Journal:  Dev Biol       Date:  2015-11-11       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.